IL283796A - Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles - Google Patents

Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles

Info

Publication number
IL283796A
IL283796A IL283796A IL28379621A IL283796A IL 283796 A IL283796 A IL 283796A IL 283796 A IL283796 A IL 283796A IL 28379621 A IL28379621 A IL 28379621A IL 283796 A IL283796 A IL 283796A
Authority
IL
Israel
Prior art keywords
receptor binding
delivery vehicles
protein complexes
subunit protein
bacterial delivery
Prior art date
Application number
IL283796A
Other languages
English (en)
Hebrew (he)
Original Assignee
Eligo Bioscience
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/696,769 external-priority patent/US11661443B2/en
Application filed by Eligo Bioscience filed Critical Eligo Bioscience
Publication of IL283796A publication Critical patent/IL283796A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2795/10342—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2795/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL283796A 2018-12-21 2021-06-07 Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles IL283796A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862783258P 2018-12-21 2018-12-21
US201962802777P 2019-02-08 2019-02-08
US16/696,769 US11661443B2 (en) 2018-11-27 2019-11-26 Chimeric receptor binding proteins for use in bacterial delivery vehicles
PCT/EP2019/082640 WO2020109339A1 (en) 2018-11-27 2019-11-26 Chimeric receptor binding proteins for use in bacterial delivery vehicles
PCT/EP2019/086990 WO2020128108A1 (en) 2018-12-21 2019-12-23 Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles

Publications (1)

Publication Number Publication Date
IL283796A true IL283796A (en) 2021-07-29

Family

ID=71101098

Family Applications (1)

Application Number Title Priority Date Filing Date
IL283796A IL283796A (en) 2018-12-21 2021-06-07 Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles

Country Status (7)

Country Link
EP (1) EP3898953A1 (https=)
JP (1) JP2022514700A (https=)
KR (1) KR20210107053A (https=)
CN (1) CN113498435A (https=)
CA (1) CA3120160A1 (https=)
IL (1) IL283796A (https=)
WO (1) WO2020128108A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11584781B2 (en) 2019-12-30 2023-02-21 Eligo Bioscience Chimeric receptor binding proteins resistant to proteolytic degradation
TR202014396A2 (tr) * 2020-09-10 2022-03-21 Univ Yildiz Teknik Mikroorganizma hedefli, antimikrobiyal bileşen/bileşenler içeren nanoformülasyonlar.
WO2022144381A1 (en) * 2020-12-30 2022-07-07 Eligo Bioscience Microbiome modulation of a host by delivery of dna payloads with minimized spread
JP2024520940A (ja) * 2021-05-12 2024-05-27 エリゴ・バイオサイエンス 産生細菌細胞及び産生方法におけるその使用
EP4342538A1 (en) * 2022-09-20 2024-03-27 Technische Universität München Simultaneous production of structural proteins from heterologous bacteriophage in cell-free expression system
EP4615856A1 (en) * 2022-11-10 2025-09-17 Laboratory Corporation of America Holdings Synthetic phage with recombinant tail-spike proteins and related methods
CN116003531B (zh) * 2022-12-28 2023-09-05 山东省农业科学院畜牧兽医研究所 噬菌体受体结合蛋白po86在大肠杆菌o抗原血清型分型鉴定中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10660943B2 (en) 2013-02-07 2020-05-26 The Rockefeller University Sequence specific antimicrobials
EP3234136B1 (en) * 2014-12-16 2024-08-21 C3J Therapeutics, Inc. Compositions of and methods for in vitro viral genome engineering

Also Published As

Publication number Publication date
CN113498435A (zh) 2021-10-12
EP3898953A1 (en) 2021-10-27
JP2022514700A (ja) 2022-02-14
CA3120160A1 (en) 2020-06-25
WO2020128108A1 (en) 2020-06-25
KR20210107053A (ko) 2021-08-31

Similar Documents

Publication Publication Date Title
IL283796A (en) Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles
IL283089A (en) Binding proteins of chimeric killers and their use in bacterial transfer media
IL284272A (en) A molecule that binds to cells
SG11201911283UA (en) Il-1beta binding antibodies for use in treating cancer
MX2021009352A (es) Compuestos de fijacion al receptor de il -2.
IL284664A (en) Multispecific binding proteins
EP3689893A4 (en) IMMUNOGLOBULIN-BINDING PROTEIN AND AFFINITY CARRIERS THEREFORE
PT3426680T (pt) Proteínas de ligação ao recetor de activina de tipo 2 e as suas utilizações
GB201802338D0 (en) Antigen binding proteins
EP3882266A4 (en) LRIG-1 PROTEIN SPECIFIC BINDING MOLECULE AND USE THEREOF
IL281351A (en) Enhanced anti-FLT3 antigen binding proteins
GB201919294D0 (en) Antibodies or binding proteins
SG11202009442YA (en) Peptides for use in immunotherapy against cancers
IL304317A (en) tgf–beta–rii binding proteins
EP3689894A4 (en) IMMUNOGLOBULIN-BINDING PROTEIN AND AFFINITY CARRIERS THEREFORE
EP3684414A4 (en) PHARMACEUTICAL CONSTRUCTIONS WITH IMPROVED BINDING AFFINITY WITH ALBUMIN
IL273202A (en) Human thrombin receptor binding proteins, PAR4
ZA201906821B (en) Anti-jagged1 antigen binding proteins
IL291364A (en) Antigen binding proteins
HK40062949A (en) Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles
HK40062948A (en) Chimeric receptor binding proteins for use in bacterial delivery vehicles
GB201703049D0 (en) Single-strand binding protein
HK40044124A (en) Trispecific antigen binding proteins
HK40017101A (en) Il-1beta binding antibodies for use in treating cancer
HK40063152A (en) Improved cell-targeting binding molecule